Dense Air and Radisys Partner on ORAN Based Actively Shared 5G Small Cell Infrastructure Software Solutions
Radisys® Corporation, a global leader of open telecom solutions, today announced its collaboration with Dense Air Networks, a global broadband solution provider, in building a first-of-its-kind 5G small cell RAN solution set that leverages licensed and shared spectrum to densify and enhance coverage and capacity in 5G standalone networks. This innovative solution from Dense Air is architected to allow both MOCN and MORAN based RAN sharing using the edge network capabilities of Radisys’ 5G RAN CU/DU software for indoor and outdoor deployments.
The partnership is based on 15 months of intense research and development work with Dense Air that utilized Radisys’ 5G CU and DU software portfolio. Dense Air, which operates shared 5G Neutral Host Infrastructure, deploys highly scalable, shared small cell solutions utilizing unique high performance RU hardware and a fully cloud-hosted, virtualized CU and DU platform; made possible by the open interfaces and advanced 3GPP features Radisys offer.
Radisys’ Connect Open RAN 5G CU/DU software hosted on the Dense Air platform is performance-optimized on multiple industry-leading processors and SoCs with:
- CU/DU split over F1 interface per 3GPP and O-RAN specifications
- CUPS architecture based CU control-plane and user-plane scaling
- Flexible lower-layer split options in DU for O-RAN 7.2x fronthaul and SCF option 6 (FAPI/nFAPI) interface, enabling advanced features such as Multi-TRP cluster cell deployment.
Radisys enables Dense Air to utilize novel mmWave fronthaul operating over O-RAN Split 6 interfaces and economically deploy shared streetside 5G small cells clusters, mounted on existing vertical assets, leveraging both licensed and shared spectrum.
Paul Senior, Founder & Chairman, Dense Air commented: “The work which we have carried out together in using O-RAN Split 6 interfaces enables us to deploy streetCell RU clusters with industry-leading 5G NR SA features. We believe this is a significant industry first and are pleased to be working with Radisys on this innovation.”
Arun Bhikshesvaran, CEO, Radisys, said: “Radisys is excited to collaborate with Dense Air in designing this highly differentiated solution that extends the capabilities of 5G networks using advanced 3GPP features and open interfaces. Our field-proven 3GPP and O-RAN compliant software, integrated and benchmarked on multiple platforms, helps Dense Air deploy a highly scalable 5G RAN solution.”
Meet with Radisys and/ or Dense Air at MWC Barcelona
Experience Radisys’ disaggregated RAN solutions, including presentations and demonstrations of Connect Open RAN software, at MWC Barcelona, booth 5B81. To schedule a meeting with Radisys’ RAN experts, contact open@radisys.com.
About Radisys
Radisys is a global leader in open telecom solutions and services. Its disaggregated platforms and integration services leverage open reference architectures and standards combined with open software and hardware, enabling service providers to drive open digital transformation. Radisys offers an end-to-end solutions portfolio from digital endpoints, to disaggregated and open access and core solutions, to immersive digital applications and engagement platforms. Its world-class and experienced network services organization delivers full lifecycle services to help service providers build and operate highly scalable and high-performance networks at optimum total cost of ownership. For more information, visit www.Radisys.com.
About Dense Air Networks
Dense Air develops shared technology platforms to accelerate the rollout of future communication solutions – to be resilient, economical and pervasive across the built environment. Through innovative public-private partnerships with cities, Dense Air delivers cost-effective 4G and 5G solutions to support a range of use cases with a single secure RAN infrastructure, including enhanced mobile broadband, IoT, public safety, first responder networks, and remote learning. For more information, visit www.denseair.net/.
Radisys® is a registered trademark of Radisys. All other trademarks are the property of their respective owners.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230226005093/en/
Contact information
Nereus for Radisys
Matt Baxter, +1-503-619-0505
radisys@nereus-worldwide.com
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Meiji Seika Pharma Partners With MBC BioLabs to Strengthen Global Innovation in Drug Discovery19.12.2025 02:00:00 CET | Press Release
Meiji Seika Pharma Co., Ltd. (Headquarters: Chuo-ku, Tokyo; President & CEO: Toshiaki Nagasato) today announced that it has entered into a partnership agreement with MBC BioLabs which is a private organization supporting the development of biotech startup companies in California’s San Francisco Bay Area. MBC BioLabs provides fully equipped research facilities and a supportive community that help biotech entrepreneurs accelerate from concept to company. By removing the burden of building and maintaining laboratory infrastructure, resident companies can focus early on research and development while efficiently advancing commercialization. Through this partnership, Meiji Seika Pharma will further advance its open-innovation initiatives and strengthen research and development in its priority therapeutic areas: infectious diseases, hematologic diseases, and immune-inflammatory diseases. By engaging with the entrepreneurs and startup community at MBC BioLabs, the company aims to discover inn
Enry's Island SpA Strengthens Its Leadership in Venture Capital with Explosive Growth and Redesigns the Future of VC Through Gaming19.12.2025 00:34:00 CET | Press Release
Enry’s Island SpA (WBAG:EIOS), the world’s first publicly listed venture builder, announces a new era of growth, innovation, and the democratization of Venture Capital (VC). The company has delivered exceptional results, consolidating its position as an industry leader through a strategic positioning in the rapidly expanding gaming market. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251218742236/en/ Record Growth and Performance Enry’s Island SpA has demonstrated an extraordinary growth trajectory and a strong financial and operational track record: Revenues: +250% year-over-year (YoY). Exit: $3.6M in exits realized via IPO. Portfolio: 1 IPO of a portfolio company completed in December 2024, with an additional 2 IPOs expected in 2026. The performance of the EIOS:VSE stock reflects this strength: Price per Share (PPS): +132% in the first half (H1) of 2025, stabilizing at a +116% YTD increase. Daily Trading Volume: peaks of
500 Global Expands Africa Presence; Selected to Advance Digital Morocco 2030 Strategy18.12.2025 21:37:00 CET | Press Release
500 Global, one of the world’s most active venture capital firms1, announced it has been selected to support the Ministry-led Startup VB initiative, a flagship program under the Digital Morocco 2030 strategy2. This announcement marks a significant milestone in 500 Global’s continued expansion across the African continent and its work collaborating with governments to strengthen national innovation ecosystems. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251218363323/en/ Announcement of 500 Global's continued expansion across Africa and support of Digital Morocco 2030 Launched by the Ministry of Digital Transition and Administrative Reform (Ministry) and deployed by TAMWILCOM, the Startup VB initiative is a flagship program under the Digital Morocco 2030 strategy. Startup VB aims to strengthen Morocco’s innovation and digital competitiveness by accelerating high-potential founders and providing the training and financing pa
Neural Concept Closes $100M Funding Round Led by Growth Equity at Goldman Sachs Alternatives to Scale AI-Native Engineering18.12.2025 17:00:00 CET | Press Release
Neural Concept, a global AI platform and leader in Engineering Intelligence powering next-generation product development, today announced it raised a $100 million Series C funding round led by Growth Equity at Goldman Sachs Alternatives, with existing investors Forestay Capital, Alven, HTGF, D.E. Shaw Ventures and Aster Capital. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251218764112/en/ Image courtesy of Neural Concept (L-R clockwise from top) Jonathan Donier, CSO & Co-founder; Thomas von Tschammer, Managing Director US & Co-founder; Théophile Allard, CTO & Co-founder; Pierre Baqué CEO & Co-founder; Philippe Cuendet, COO Neural Concept is redefining engineering workflows with CAD-native enterprise AI that understands geometry, constraints and design intent. By helping its customers build and deploy physics-aware design copilots, the platform enables teams to explore millions of design options earlier and avoid costly la
Croma-Pharma Introduces New Medical Device for the Preparation of Autologous PRP | Fluid- PRF18.12.2025 16:57:00 CET | Press Release
Croma-Pharma, a global player in minimally invasive aesthetic medicine, proudly announces the launch of its new medical device that is used for the preparation of autologous Platelet-Rich Plasma (PRP) | Fluid-Platelet-Rich Fibrin (Fluid-PRF).1 This launch represents continued progress in Croma’s mission to provide healthcare professionals state-of-the-art tools for their practice. With its innovative design and optimized separation technology, Exprecell™ enables the efficient preparation of autologous blood concentrates, without the use of anticoagulants, resulting in the formation of Fluid-PRF, a biologically active concentrate that retains the regenerative properties of platelets and leukocytes, yet stays liquid for a defined period.1 What makes Exprecell™ special? MDR certification: Exprecell™ is MDR-certified, meeting stringent EU regulatory requirements to ensure the safe, controlled and standardized preparation of autologous Platelet-Rich Plasma (PRP) | Fluid-Platelet-Rich Fibrin
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom